Ivan Gergel Insider Profile
4 Followers
Ivan Gergel, SVP & CMO at Nektar Therapeutics, holds 56.55K shares in Nektar Therapeutics (Ticker: NKTR), holds ― shares in Neurotrope Inc (Ticker: ~NTRP), holds 0.00 shares in Corium (Ticker: CORI).
Ivan Gergel's Trading History
| NKTRNektar Therapeutics | Nov 17, 2017 | SVP & CMO | Uninformative Sell | 222.12K | $2.11M | |
| ENDPQEndo International | Mar 11, 2014 | ― | Informative Sell | 5.48M | $331.79 | |
| ~FRXForest Labs | ― | ― | ― | ― | ||
| CORICorium | ― | ― | ― | $0.00 | ||
| ~NTRPNeurotrope Inc | ― | ― | ― | ― |
You May Also Like
Ivan Gergel insider profile FAQ
What is the percentage of profitable transactions made by Ivan Gergel?
The percentage of profitable transactions made by Ivan Gergel is 0%.
What is the average return per transaction made by Ivan Gergel?
The average return per transaction made by Ivan Gergel is -140.50%.
What stocks does Ivan Gergel hold?
Ivan Gergel holds: NKTR, ~NTRP, CORI, ENDPQ, ~FRX stocks.
What was Ivan Gergel’s latest transaction?
Ivan Gergel’s latest transaction was an Uninformative Sell of $222.12K.
What was Ivan Gergel's most profitable transaction?
Ivan Gergel’s most profitable transaction was an Informative Sell of NKTR stock on August 17, 2016. The return on the trade was -4.30%.
What is Ivan Gergel's role in Nektar Therapeutics?
Ivan Gergel's role in Nektar Therapeutics is SVP & CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
